Bristol-Myers Squibb Co. (BMY) PT Lowered to $51 at BofA/Merrill Lynch

February 19, 2019 6:33 AM
BofA/Merrill Lynch analyst Jason Gerberry lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change